William Andrew Macan, EVP, CLO and CS of Neuronetics, Inc. ($STIM), made four open market sales of company stock over the past year, totaling about $34,000. His latest sale occurred on March 4, 2026. These transactions rank 10,713th out of 11,678 individual insiders by sale value, well below the average of $8.6 million across 6.4 sales per insider. Macan recorded no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | S | Common Stock | 16005 | $1.34 | 897,270.0000 | 65,951,000 | 1.75% | 0.02% |
| March 17, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | A | Common Stock | 33750 | $0.00 | 913,275.0000 | 67,309,000 | 3.84% | 0.05% |
| March 4, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | S | Common Stock | 609 | $1.34 | 879,525.0000 | 67,309,000 | 0.07% | 0.00% |
| Feb. 26, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | S | Common Stock | 3427 | $1.35 | 880,134.0000 | 67,309,000 | 0.39% | 0.01% |
| Feb. 23, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | A | Common Stock | 210000 | $0.00 | 883,561.0000 | 67,309,000 | 31.18% | 0.31% |
| Feb. 12, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | S | Common Stock | 14120 | $1.65 | 673,561.0000 | 67,309,000 | 2.05% | 0.02% |
| Feb. 10, 2026 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, CLO and CS | S | Common Stock | 3485 | $1.55 | 687,681.0000 | 67,309,000 | 0.50% | 0.01% |
| Dec. 30, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Common Stock | 164361 | $0.00 | 691,166.0000 | 67,309,000 | 31.20% | 0.24% |
| Feb. 24, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Performance Restricted Stock Unit | 78750 | $0.00 | 78,750.0000 | 31,734,000 | 9999.99% | 0.25% |
| March 4, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 377 | $4.48 | 526,805.0000 | 31,734,000 | 0.07% | 0.00% |
| Feb. 24, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Performance Restricted Stock Unit | 78750 | $0.00 | 78,750.0000 | 31,734,000 | 9999.99% | 0.25% |
| Feb. 24, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Common Stock | 157500 | $0.00 | 527,182.0000 | 31,734,000 | 42.60% | 0.50% |
| Feb. 14, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 18965 | $4.11 | 369,682.0000 | 31,734,000 | 4.88% | 0.06% |
| Feb. 12, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 12175 | $3.83 | 388,647.0000 | 31,734,000 | 3.04% | 0.04% |
| Feb. 10, 2025 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 1970 | $3.28 | 400,822.0000 | 31,734,000 | 0.49% | 0.01% |
| Dec. 10, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Performance Restricted Stock Unit | 135000 | $0.00 | 135,000.0000 | 30,267,000 | 9999.99% | 0.45% |
| Oct. 8, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 1541 | $0.82 | 402,792.0000 | 30,267,000 | 0.38% | 0.01% |
| Feb. 29, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 6026 | $2.94 | 389,333.0000 | 28,658,000 | 1.52% | 0.02% |
| Feb. 29, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Common Stock | 15000 | $0.00 | 404,333.0000 | 28,658,000 | 3.85% | 0.05% |
| Feb. 28, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 22377 | $3.16 | 395,359.0000 | 28,658,000 | 5.36% | 0.08% |
| Feb. 14, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 15621 | $3.38 | 417,736.0000 | 28,658,000 | 3.60% | 0.05% |
| Feb. 6, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 5385 | $3.39 | 433,357.0000 | 28,658,000 | 1.23% | 0.02% |
| Feb. 5, 2024 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | A | Common Stock | 90000 | $0.00 | 438,742.0000 | 28,658,000 | 25.81% | 0.31% |
| Dec. 20, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 11664 | $2.70 | 360,405.0000 | 42,232,942 | 3.13% | 0.03% |
| Dec. 19, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 11664 | $2.24 | 372,069.0000 | 42,232,942 | 3.04% | 0.03% |
| Dec. 21, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 11663 | $2.52 | 348,742.0000 | 42,232,942 | 3.24% | 0.03% |
| Oct. 6, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 1469 | $1.16 | 383,733.0000 | 42,232,942 | 0.38% | 0.00% |
| July 11, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 2645 | $2.13 | 385,202.0000 | 28,590,000 | 0.68% | 0.01% |
| March 7, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 12692 | $4.59 | 387,847.0000 | 26,900,000 | 3.17% | 0.05% |
| Feb. 15, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 11974 | $5.90 | 411,583.0000 | 26,900,000 | 2.83% | 0.04% |
| Feb. 16, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | EVP, GC, CCO and CS | S | Common Stock | 11044 | $5.91 | 400,539.0000 | 26,900,000 | 2.68% | 0.04% |
| Feb. 7, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | SVP and General Counsel | S | Common Stock | 5162 | $5.99 | 333,557.0000 | 26,900,000 | 1.52% | 0.02% |
| Feb. 8, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | SVP and General Counsel | A | Common Stock | 90000 | $0.00 | 423,557.0000 | 26,900,000 | 26.98% | 0.33% |
| Jan. 23, 2023 | Neuronetics, Inc. | $STIM | MACAN WILLIAM ANDREW | SVP and General Counsel | S | Common Stock | 16046 | $5.96 | 338,719.0000 | 26,900,000 | 4.52% | 0.06% |